Literature DB >> 2464903

Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.

C Nordin1.   

Abstract

In 28 patients with primary depression, relationships were sought between rating scores on the Montgomery-Asberg Depression Rating Scale and the concentrations of the monoamine metabolites 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and 4-hydroxy-3-methoxyphenylglycol (HMPG) in cerebrospinal fluid (CSF). Among the single items in the rating scale, reported sadness correlated negatively with HMPG. No other significant relationships were found in the total group of patients. However, in subgroups with low or high concentrations of monoamine metabolites, several significant relationships were found, such as a negative correlation between inner tension and concentration difficulties, respectively, and 5-HIAA in the low-HMPG subgroup. Curvilinear relationships were found between pessimistic thoughts and 5-HIAA in the high-5-HIAA subgroup and between apparent sadness and 5-HIAA in the low-HMPG subgroup. Suicidal thoughts tended to correlate in a curvilinear way with the ratio of HMPG/5-HIAA in the low-HVA and the high-HMPG subgroups, but the curves were mirrored. The results indicate that relationships between clinical symptoms and monoamine metabolite homeostasis in CSF are qualitatively and quantitatively different in defined high-and low-monoamine subgroups of depressed patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2464903     DOI: 10.1111/j.1600-0447.1988.tb06411.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  2 in total

1.  A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.

Authors:  A Villaseñor; A Ramamoorthy; M Silva dos Santos; M P Lorenzo; G Laje; C Zarate; C Barbas; I W Wainer
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile.

Authors:  Rima Kaddurah-Daouk; Peixiong Yuan; Stephen H Boyle; Wayne Matson; Zhi Wang; Zhao Bang Zeng; Hongjie Zhu; George G Dougherty; Jeffrey K Yao; Guang Chen; Xavier Guitart; Paul J Carlson; Alexander Neumeister; Carlos Zarate; Ranga R Krishnan; Husseini K Manji; Wayne Drevets
Journal:  Sci Rep       Date:  2012-09-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.